Theratechnologies THTX
$ 1.21
-0.82%
Annual report 2023
added 11-09-2024
Theratechnologies Balance Sheet 2011-2024 | THTX
Annual Balance Sheet Theratechnologies
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | 40.1 M | 26.6 M | 10.2 M | 6.74 M | 9.26 M | 2.28 M | 13.3 M | -900 K | -1.5 M | -2.5 M | ||
Long Term Debt |
- | - | - | 52.4 M | 55.3 M | 49.2 M | 3.36 M | 6.59 M | 9.26 M | 10.1 M | - | - | - |
Long Term Debt Current |
421 K | 476 K | 463 K | 425 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 55 M | 55.6 M | 49.2 M | 3.36 M | 7.88 M | 9.78 M | 10.1 M | 1.6 M | 7.3 M | 4.9 M |
Total Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
98.6 M | 116 M | 101 M | 96.9 M | 2.95 M | 76.1 M | 24.6 M | 19.3 M | 22.3 M | 18.6 M | 6 M | 13.7 M | 16.2 M |
Deferred Revenue |
- | - | - | 50 K | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | -300 M | -277 M | -265 M | -223 M | -208 M | -208 M | -211 M | -255 M | -268 M | -248 M |
Total Assets |
77.8 M | 93.3 M | 119 M | 100 M | 2.95 M | 111 M | 56.5 M | 39.2 M | 37.1 M | 24.5 M | 23.4 M | 36.5 M | 51.9 M |
Cash and Cash Equivalents |
34.1 M | 23.9 M | 20.4 M | 12.7 M | 28.7 M | 39 M | - | - | - | - | - | - | - |
Book Value |
-20.9 M | -22.6 M | 17.8 M | 3.22 M | - | 35 M | 31.9 M | 19.9 M | 14.8 M | 5.91 M | 17.4 M | 22.8 M | 35.7 M |
Total Shareholders Equity |
- | - | - | 3.22 M | 24.8 M | 35 M | 33.4 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Theratechnologies
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | 2.06 M | - | - | - | 2.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 56.4 M | - | - | - | 55 M | - | - | - | 55.6 M | - | - | - | 49.2 M | - | - | - | 3.52 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | 101 M | - | - | - | 96.9 M | - | - | - | 2.95 M | - | - | - | 76.1 M | - | - | - | 25.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | -335 M | - | - | - | -300 M | - | - | - | - | - | - | - | -265 M | - | - | - | -261 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | - | 119 M | - | - | - | 100 M | - | - | - | 2.95 M | - | - | - | 111 M | - | - | - | 59.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | - | 20.4 M | - | - | - | 12.7 M | - | - | - | 28.7 M | - | - | - | 39 M | - | - | - | 1.36 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | - | 17.8 M | - | - | - | 3.22 M | - | - | - | - | - | - | - | 35 M | - | - | - | 33.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | - | 17.8 M | - | - | - | 3.22 M | - | - | - | 24.8 M | - | - | - | 35 M | - | - | - | 33.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency